COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

A Feasibility Trial of Nivolumab With Neoadjuvant CF or DCF Therapy for Locally Advanced Esophageal Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03914443
Recruitment Status : Active, not recruiting
First Posted : April 16, 2019
Last Update Posted : September 10, 2020
Ono Pharmaceutical Co. Ltd
Fiverings Co., Ltd.
Information provided by (Responsible Party):
National Cancer Center, Japan

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : August 1, 2021
Estimated Study Completion Date : February 1, 2022